Recent News

• 05.21.2025 - Sidoti Micro Cap Conference
• 05.19.2025 - Lifeward Names Mark Grant as New CEO
• 05.19.2025 - Lifeward to Present at Sidoti Virtual Investor Conference on May 21
• 05.15.2025 - Q1 2025 Lifeward, Inc. Earnings Conference Call
• 05.15.2025 - Lifeward Ltd. Reports First Quarter 2025 Financial Results
• 05.08.2025 - Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
• 05.07.2025 - Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025
• 04.29.2025 - First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
• 04.24.2025 - Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton
• 04.15.2025 - Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

Recent Filings

• 05.19.2025 - 8-K Current report
• 05.19.2025 - EX-99.1 EX-99.1
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.15.2025 - S-3 Registration statement under Securities Act of 1933
• 05.15.2025 - 8-K Current report
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - EX-99.1 EX-99.1
• 04.15.2025 - EX-99.1 EX-99.1
• 04.15.2025 - 8-K Current report
• 04.14.2025 - 8-K Current report